A detailed history of Heartland Advisors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Heartland Advisors Inc holds 24,108 shares of CRL stock, worth $4.01 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
24,108
Previous 34,698 30.52%
Holding current value
$4.01 Million
Previous $7.17 Million 33.74%
% of portfolio
0.25%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$187.96 - $245.29 $1.99 Million - $2.6 Million
-10,590 Reduced 30.52%
24,108 $4.75 Million
Q2 2024

Aug 08, 2024

BUY
$206.39 - $268.73 $1.68 Million - $2.19 Million
8,151 Added 30.7%
34,698 $7.17 Million
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $5.4 Million - $7.26 Million
26,547 New
26,547 $7.19 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.46B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Heartland Advisors Inc Portfolio

Follow Heartland Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.